These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10658234)

  • 41. Prescription prices under the New York generic substitution law.
    Francetić I; Lasagna L; Weintraub M; Karch FE
    Ann Intern Med; 1980 Mar; 92(3):419-23. PubMed ID: 7356236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
    Maly J; Dosedel M; Kubena A; Vlcek J
    Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prescription, dispensation and sustitution of prescription forms of omeprazole].
    Vaquero MB
    Gac Sanit; 2003; 17(4):296-301. PubMed ID: 12975053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Generic drugs and legal incentives: which impact?].
    Livio F; Buclin T; Pannatier A; Biollaz J
    Rev Med Suisse; 2006 Apr; 2(61):966-9. PubMed ID: 16686328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical interventions on prescriptions in Norwegian community and hospital pharmacies.
    Vik S; Weidemann P; Gangås IEM; Knapstad SE; Haavik S
    Int J Clin Pharm; 2021 Aug; 43(4):872-877. PubMed ID: 33155093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists' Substitution Beliefs and Practices.
    Sarpatwari A; Lee MP; Gagne JJ; Lu Z; Dutcher SK; Jiang W; Campbell EG; Kesselheim AS
    Clin Pharmacol Ther; 2018 Jun; 103(6):1093-1099. PubMed ID: 29165800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prospective study of the factors associated with the acceptance of generics substitution by patients and their liberal doctors].
    Iskounen S; Simoneau G; Mouly S
    Rev Med Interne; 2018 Nov; 39(11):849-854. PubMed ID: 29290412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences.
    Toverud EL; Røise AK; Hogstad G; Wabø I
    Eur J Clin Pharmacol; 2011 Jan; 67(1):33-8. PubMed ID: 21104408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Perceptions and utilization of generic medicines in Guatemala: a mixed-methods study with physicians and pharmacy staff.
    Flood D; Mathieu I; Chary A; García P; Rohloff P
    BMC Health Serv Res; 2017 Jan; 17(1):27. PubMed ID: 28086866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra].
    Ansa Erice I; Agudo Pascual C; Artazcoz Sanz M; Carnicero Giménez de Azcárate J
    Aten Primaria; 1996 Apr; 17(6):411-4. PubMed ID: 8672647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation.
    Blankart KE; Vandoros S
    PLoS One; 2024; 19(5):e0301716. PubMed ID: 38696520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solution-driven approaches to generic substitution challenges - a survey among international experts.
    Drozdowska A; Hermanowski T
    Fundam Clin Pharmacol; 2015 Dec; 29(6):592-603. PubMed ID: 26214281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines].
    Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S
    Therapie; 2008; 63(1):11-7. PubMed ID: 18387271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Proprietary Names by Prescribers for Generic Products.
    Borders-Hemphill V; Chan IZ; Brown K; Rider B; Taylor K; Chai G
    Ther Innov Regul Sci; 2018 Mar; 52(2):256-260. PubMed ID: 29714516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating community pharmacists' perspectives and practices concerning generic medicines substitution in Saudi Arabia: A cross-sectional study.
    Alkhuzaee FS; Almalki HM; Attar AY; Althubiani SI; Almuallim WA; Cheema E; Hadi MA
    Health Policy; 2016 Dec; 120(12):1412-1419. PubMed ID: 28228231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy.
    Colombo GL; Agabiti-Rosei E; Margonato A; Mencacci C; Montecucco CM; Trevisan R; Catapano AL
    Atheroscler Suppl; 2016 Jun; 21():1-8. PubMed ID: 26948872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.